Zobrazeno 1 - 4
of 4
pro vyhledávání: '"59"'
Autor:
Masashi Goto, Takeshi Iwanaga, Toshifusa Nakajima, Tsuyoshi Kito, Kenzo Okabayashi, Michiro Sasaki, Atsushi Nashimoto, Masatsugu Kitamura
Publikováno v:
The Lancet. 354:273-277
Summary Background To study the survival benefit of adjuvant chemotherapy in gastric cancer, seven cancer centres in Japan carried out a phase III clinical trial of adjuvant chemotherapy after curative gastrectomy for macroscopically serosa-negative
Autor:
Jean-Jacques Grob, Jean-Pierre Cesarini, Catherine Lok, Brigitte Dréno, Michèle Delaunay, Claude Chastang, Bernard Guillot, Pierre Souteyrand, Jean Jacques Bonerandi, Didier Cupissol, Bruno Sassolas, Sylvie Lionnet, Pauline de la Salmoniere
Publikováno v:
The Lancet. 351:1905-1910
Summary Background Owing to the limited efficacy of therapy on melanoma at the stage of distant metastases, a well-tolerated adjuvant therapy is needed for patients with high-risk primary melanoma. Our hypothesis was that an adjuvant treatment with l
Publikováno v:
The Lancet. 343:1122-1126
In Japan the standard adjuvant treatment after resection of gastric cancer is intravenous mitomycin plus oral fluorouracil. We have assessed the efficacy of protein-bound polysaccharide (PSK) in addition to standard chemotherapy in patients who had u
Publikováno v:
The Lancet. 340:1256-1257
We compared the efficacy of amphotericin B and pentamidine isethionate in a prospective randomised trial in 120 uncomplicated and parasitologically confirmed cases of antimony-unresponsive kala-azar. Doses were twenty intramuscular injections of pent